Role of Curcumin and Fenofibrate on Cardiovascular Events in Type 2 Diabetes Mellitus.

Background and aim Type 2 diabetes mellitus is associated with cardiovascular complications that account for a high percentage of mortality and increase the clinical burden on the healthcare system. Herbal products like curcumin and chemical drugs like fenofibrate were found to be effective in decreasing complications associated with heart in type 2 diabetes. The aim of this study is to evaluate the role of curcumin and fenofibrate on cardiovascular complications in type 2 diabetes in a minireview.Methods We reviewed the online databases PubMed, Science Direct, and Google Scholar for articles discussing the impact of curcumin or fenofibrate in improving lipid profile in patients with type 2 diabetes. Results The prior studies demonstrated the impact of consuming curcumin or fenofibrate to improve the lipid profile in people with type 2 diabetes. Triglycerides (TG), low-density lipoprotein (LDL), and total cholesterol (TC) were reduced with either curcumin or fenofibrate. In contrast, high-density lipoprotein (HDL) levels were increased. Conclusions Curcumin or fenofibrate consumption in patients with type 2 diabetes enhances lipid profile, hence decreasing insulin resistance and reducing cardiovascular complications.

Authors

Institutions

Publication Details

Journal
Journal of Advanced Medical and Pharmaceutical Research
Published
2025-02-13
DOI
https://doi.org/10.21608/jampr.2025.354114.1086
Primary Topic
Natural Antidiabetic Agents Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Role of Curcumin and Fenofibrate on Cardiovascular Events in Type 2 Diabetes Mellitus.

Rehab H. Werida, Nashwa M. El-Gharbawy, Eman Nada, Haidy A. Abass
Journal of Advanced Medical and Pharmaceutical Research
Natural Antidiabetic Agents Studies
article

Role of Curcumin and Fenofibrate on Cardiovascular Events in Type 2 Diabetes Mellitus.

Rehab H. Werida, Nashwa M. El-Gharbawy, Eman Nada, Haidy A. Abass
article en

Abstract

Background and aim Type 2 diabetes mellitus is associated with cardiovascular complications that account for a high percentage of mortality and increase the clinical burden on the healthcare system. Herbal products like curcumin and chemical drugs like fenofibrate were found to be effective in decreasing complications associated with heart in type 2 diabetes. The aim of this study is to evaluate the role of curcumin and fenofibrate on cardiovascular complications in type 2 diabetes in a minireview.Methods We reviewed the online databases PubMed, Science Direct, and Google Scholar for articles discussing the impact of curcumin or fenofibrate in improving lipid profile in patients with type 2 diabetes. Results The prior studies demonstrated the impact of consuming curcumin or fenofibrate to improve the lipid profile in people with type 2 diabetes. Triglycerides (TG), low-density lipoprotein (LDL), and total cholesterol (TC) were reduced with either curcumin or fenofibrate. In contrast, high-density lipoprotein (HDL) levels were increased. Conclusions Curcumin or fenofibrate consumption in patients with type 2 diabetes enhances lipid profile, hence decreasing insulin resistance and reducing cardiovascular complications.

Journal of Advanced Medical and Pharmaceutical ResearchVol. 0(0)
Damanhour University (EG), Tanta University (EG), Ministry of Health and Population (EG)
Zero hunger
Openalex Percentile: Top 96%
Natural Antidiabetic Agents Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Role of Curcumin and Fenofibrate on Cardiovascular Events in Type 2 Diabetes Mellitus. — Rehab H. Werida, Nashwa M. El-Gharbawy, et al. · Journal of Advanced Medical and Pharmaceutical Research (2025) | TGRS Research Map | TGRS